“…Furthermore, a great body of evidence associates neurotoxicity with a reduction of NKA activity, suggesting that reduction in NKA activity may be a link between several common neurotoxic mechanisms [14,15,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79]. Loss of NKA is associated with autism [65,66,69]; Alzheimer’s disease [66,80,81]; Parkinson’s disease [82]; amyotrophic lateral sclerosis [70,82]; Down syndrome and Huntington’s disease [69]; depression and mood disorders [71,72,73,74]; bipolar disorder [14,75,76] and schizophrenia [15,77,79], as well as in animal models of depression [83,84]. Interestingly, NKA activity has been found to be significantly lower in subjects with phenylketonuria [85], a disease associated with intellectual disability, seizures, behavioural problems and mental disorders.…”